AIM ImmunoTech Financial Overview
AIM ImmunoTech's market cap is currently $3.82M. The company's EPS TTM is $-1.57; its P/E ratio is -0.06; AIM ImmunoTech is scheduled to report earnings on November 18, 2025, and the estimated EPS forecast is $-0.94. See an overview of income statement, balance sheet, and cash flow financials.